iStock Rating

B

Details...

Enter Symbol

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

Sector: Medical

Current Price : $262.42

52 Week Low
$110.6652 Week High
$262.42

Company

Company Profile

Community

Stock Sentiment

Whisper Estimates

Enter Estimates

Analysis

Charts

Technical Charts

Analyst

Analyst Ratings

Analyst Estimates

Sales Estimates

Ratios

Financial Ratios

Shares Outstanding: 97M
Market Cap: $20.72B
Avg Volume: 767094
P/E Ratio: 54.650
PEG Ratio: 1.310

regn three month chart

regn three month chart

regn six month chart

regn one year chart

regn two year month chart

Opinion and Analysis

Regeneron Pharmaceuticals, Inc: Eylea Fundamentals Improving Amid Thinning Competition
May 09, 2013 11:25 AM | REGN
Insider Weekends – May 3, 2013
May 06, 2013 10:34 AM | AN, BA, BCA, COO, IVC, NFLX
Stocks Jump 1 Pct On Strong Jobs Data; AIG Gains
May 03, 2013 04:10 PM | AIG, ARNA, KFT, REGN, TDC, WTW
More Articles on REGN..

Press Releases

Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 21, 2013 08:15 AM | REGN, SNY
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 15, 2013 01:00 AM | REGN, SNY
Regeneron Announces Upcoming 2013 Investor Conference Presentations
May 08, 2013 09:30 AM | REGN
More Press Releases on REGN..

SEC Filings

Form 4 REGENERON PHARMACEUTICAL For: Mar 13 Filed by: SCHLEIFER LEONARD S (10K)
Mar 15, 2013 05:22 PM
Form 4 REGENERON PHARMACEUTICAL For: Mar 05 Filed by: SCHLEIFER LEONARD S (10K)
Mar 07, 2013 05:28 PM
Form 4 REGENERON PHARMACEUTICAL For: Feb 26 Filed by: SHOOTER ERIC M (10K)
Feb 28, 2013 02:48 PM

Sentiment Survey

Avg. Short Term

Avg. Long Term

Avg. Grade

More Details

Share Performance

Period	REGN	Compare to S&P
YTD	24.26 %	13.95 %
4 Weeks	23.31 %	23.44 %
12 Weeks	21.84 %	17.74 %
More...

Financial Ratios

regn Financial Ratios Chart

Earnings Performance

EPS Growth in Last Quarter: -31.64 %

EPS Growth in Last Year: 324.07 %

Sales Growth in Last Quarter: -3.06 %

Sales Growth in Last Quarter: 237.14 %

More...

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.